Rate of, and risk factors for, white matter hyperintensity growth: a systematic review and meta- analysis with implications for clinical trial design R Brown, A Low, HS Markus Journal of Neurology, Neurosurgery and Psychiatry, 2021 | 31 | 2021 |
Cognitive impact of cerebral microbleeds in patients with symptomatic small vessel disease S Nannoni, L Ohlmeier, RB Brown, RG Morris, AD MacKinnon, HS Markus, ... International Journal of Stroke 17 (4), 415-424, 2022 | 29 | 2022 |
Do cerebral small vessel disease and multiple sclerosis share common mechanisms of white matter injury? A genetic study RB Brown, M Traylor, S Burgess, S Sawcer, HS Markus Stroke 50 (8), 1968-1972, 2019 | 16 | 2019 |
MINocyclinE to Reduce inflammation and blood brain barrier leakage in small Vessel diseAse (MINERVA) trial study protocol RB Brown, DJ Tozer, L Loubière, YT Hong, TD Fryer, GB Williams, ... European Stroke Journal 7 (3), 323-330, 2022 | 13 | 2022 |
Prevalence of, and risk factors for, cognitive impairment in lacunar stroke L Ohlmeier, S Nannoni, C Pallucca, RB Brown, L Loubiere, HS Markus, ... International Journal of Stroke 18 (1), 62-69, 2023 | 10 | 2023 |
Do regions of increased inflammation progress to new white matter hyperintensities?: A longitudinal positron emission tomography-magnetic resonance imaging study DJ Tozer, RB Brown, J Walsh, YT Hong, GB Williams, JT O’Brien, ... Stroke 54 (2), 549-557, 2023 | 4 | 2023 |
How often does white matter hyperintensity volume regress in cerebral small vessel disease? RB Brown, DJ Tozer, M Egle, AM Tuladhar, FE de Leeuw, HS Markus International Journal of Stroke 18 (8), 937-947, 2023 | 3 | 2023 |
Individual markers of cerebral small vessel disease and domain‐specific quality of life deficits J Fernando, RB Brown, H Edwards, M Egle, HS Markus, J Tay Brain and Behavior 11 (5), e02106, 2021 | 3 | 2021 |
MINocyclinE to Reduce inflammation and blood‐brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double‐blind, placebo‐controlled experimental … RB Brown, DJ Tozer, L Loubière, EL Harshfield, YT Hong, TD Fryer, ... Alzheimer's & Dementia, 2024 | | 2024 |
Are central and systemic inflammation associated with fatigue in cerebral small vessel disease? AA Jolly, RB Brown, DJ Tozer, YT Hong, TD Fryer, FI Aigbirhio, JT O’Brien, ... International Journal of Stroke, 17474930241245613, 2024 | | 2024 |
Disease mechanisms and markers of progression in cerebral small vessel disease R Brown | | 2024 |
Phenotypes associated with genetic determinants of type I interferon regulation in the UK Biobank: a protocol B Rioux, M Chong, R Walker, S McGlasson, K Rannikmae, DL McCartney, ... medRxiv, 2023.10. 12.23296935, 2023 | | 2023 |
REGRESSION OF WHITE MATTER HYPERINTENSITY LESIONS IN CEREBRAL SMALL VESSEL DISEASE R Brown, D Tozer, A Tuladhar, FE De Leeuw, HS Markus INTERNATIONAL JOURNAL OF STROKE 16 (2_ SUPPL), 14-14, 2021 | | 2021 |
COGNITIVE IMPACT OF CEREBRAL MICROBLEEDS IN PATIENTS WITH SYMPTOMATIC SMALL VESSEL DISEASE S Nannoni, L Ohlmeier, L Loubiere, R Brown, E Harshfield, R Morris, ... INTERNATIONAL JOURNAL OF STROKE 15 (1_ SUPPL), 36-36, 2020 | | 2020 |